药物输送系统与建模 395条(本栏目收费,不能显示细节,电话15274084725)
2 Benefits and Drawbacks of the Pulmonary Route Over Other Administration Routes, 275 275
3 Marketed Inhalable Products and Patient Compliance, 280 280
3.1 Inhalable Drugs Commercially Available in US and UE Markets, 280 280
3.2 Patient Compliance to Aerosol Therapy, 281 281
4 The Role of Formulation for Controlled PDD, 284 284
3.3 Prolonged-Release Dosage Form, 316 316
3.4 Controlled-Drug Release Dosage Form, 316 316
3.5 Delayed-Drug Release Dosage Form, 316 316
4 Polymers used in Controlled-Release Systems, 316 316
4.1 Hydrophilic Polymers, 318 318
4.2 Hydrophobic Polymers, 319 319
5 Types of Controlled-Release Drug Delivery Systems, 320 320
5.1 Diffusion-Controlled Systems, 320 320
5.2 Dissolution-controlled systems, 320 320
5.3 Dissolution-diffusion-controlled systems or hybrid systems, 321 321
6 Drug Release Characterization From Controlled-Drug Delivery Systems, 322 322
6.1 Evaluation of Drug Release Characteristics From Delivery Systems, 322 322
6.2 Swelling and erosion characterization for controlled-release dosage form, 326 326
6.3 Pharmacokinetic Evaluation of Solid Oral-Controlled Dosage Forms, 327 327
8 Future Prospects, 328 328
19 Advanced Solid Oral Controlled-Release Formulations, 333 333
Neha Dabholkar, P. Swetha, Mitesh Bhansali, 0
Sunil Kumar Dubey, Gautam Singhvi 0
2 Gastro-Retentive Drug Delivery Systems, 333 333
2.1 Floating Systems, 335 335